X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (164) 164
Publication (15) 15
Patent (4) 4
Conference Proceeding (2) 2
Book / eBook (1) 1
Book Chapter (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (55) 55
index medicus (49) 49
female (37) 37
male (28) 28
aged (19) 19
middle aged (19) 19
adult (18) 18
medicine (15) 15
cell line, tumor (14) 14
hematology (14) 14
oncology (13) 13
apoptosis (12) 12
cancer (12) 12
multiple myeloma (12) 12
natural-killer-cells (10) 10
animals (9) 9
cell biology (9) 9
surveys and questionnaires (9) 9
aged, 80 and over (8) 8
killer cells, natural - immunology (8) 8
multiple myeloma - immunology (8) 8
public aspects of medicine (8) 8
signal transduction (8) 8
abridged index medicus (7) 7
blotting, western (7) 7
immunology (7) 7
italy - epidemiology (7) 7
medicine, research & experimental (7) 7
mice (7) 7
multiple myeloma - pathology (7) 7
public health (7) 7
research paper (7) 7
adolescent (6) 6
analysis (6) 6
apoptosis - drug effects (6) 6
article (6) 6
expression (6) 6
health aspects (6) 6
internal medicine (6) 6
italy (6) 6
oligonucleotide array sequence analysis (6) 6
public, environmental & occupational health (6) 6
research article (6) 6
smoking (6) 6
acute myeloid-leukemia (5) 5
antineoplastic agents - pharmacology (5) 5
biochemistry & molecular biology (5) 5
cell proliferation - drug effects (5) 5
child (5) 5
class-i (5) 5
doaj:health sciences (5) 5
doaj:public health (5) 5
gene expression (5) 5
hematology, oncology and palliative medicine (5) 5
immunotherapy (5) 5
multiple myeloma - metabolism (5) 5
mutation (5) 5
natural killer cells (5) 5
proliferation (5) 5
proteins (5) 5
research (5) 5
tobacco (5) 5
tumor cells, cultured (5) 5
up-regulation (5) 5
activation (4) 4
antigens, differentiation, t-lymphocyte - metabolism (4) 4
attitudes (4) 4
care and treatment (4) 4
children (4) 4
cigarettes (4) 4
cost-benefit analysis (4) 4
diabetes (4) 4
disease (4) 4
dna damage (4) 4
doxorubicin - pharmacology (4) 4
drug synergism (4) 4
follow-up studies (4) 4
gene (4) 4
gene expression regulation, neoplastic (4) 4
growth (4) 4
health care sciences & services (4) 4
in-vivo (4) 4
killer cells, natural - metabolism (4) 4
knowledge (4) 4
leukemia (4) 4
leukemia, myeloid, acute - drug therapy (4) 4
leukemia, myeloid, acute - pathology (4) 4
lymphocytes (4) 4
metabolism (4) 4
mortality (4) 4
multidisciplinary sciences (4) 4
neoplasms. tumors. oncology. including cancer and carcinogens (4) 4
nkg2d ligands (4) 4
phosphorylation (4) 4
prevention (4) 4
prognosis (4) 4
prospective studies (4) 4
proto-oncogene proteins c-akt - metabolism (4) 4
quality of life (4) 4
receptor (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 2751 - 2751
Abstract We have demonstrated that selective MEK inhibitors (MEK-I) significantly inhibit in vitro the growth of AML cell lines and primary AML blasts... 
Journal Article
European Journal of Clinical Nutrition, ISSN 0954-3007, 2019, Volume 74, Issue 1, pp. 167 - 175
To investigate the effects of cholecalciferol supplementation on the progression of motor disability in a cohort of amyotrophic lateral sclerosis (ALS)... 
Journal Article
AIP Conference Proceedings, ISSN 0094-243X, 07/2018, Volume 1981, Issue 1
The flammability behavior of an epoxy resin, modified by the addition of Posidonia Oceanica at three concentration levels (8%, 10%,12%), has been investigated... 
Posidonia Oceanica | fire | epoxy | Hybrid composites | Scanning electron microscopy | Polymer matrix composites | Epoxy resins | Cone calorimeters | Flammability | Dispersion
Journal Article
Cancers, ISSN 2072-6694, 12/2018, Volume 10, Issue 12
Natural Killer (NK) cells play a pivotal role in the immunosurveillance of Multiple Myeloma (MM), but it is still undefined whether the NK cell functional... 
Natural killer cells | HSCT | Immunotherapy | Multiple myeloma
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 21, pp. 5045 - 5045
Abstract Glycolysis is the central axis of cellular metabolism. The cancer cell bioenergetic status heavily relies on high glycolytic rates, even in aerobic... 
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 21, pp. 4222 - 4222
Abstract Acute myeloid leukemia (AML) has been characterized by a growing number of recurrent genetic alterations, frequently causing the constitutive... 
Journal Article
Blood, ISSN 0006-4971, 11/2012, Volume 120, Issue 21, pp. 1371 - 1371
Abstract Abstract 1371 Aberrant signal transduction pathways influence metabolic changes in neoplastic cells. It is well established, in fact, that cancer... 
Journal Article
Telemedicine and e-Health, ISSN 1530-5627, 08/2013, Volume 19, Issue 8, p. 647
Journal Article
Blood, ISSN 0006-4971, 11/2010, Volume 116, Issue 21, pp. 4946 - 4946
Abstract Abstract 4946 Histone deacetylase inhibitors (HDAC-I) are a class of agents with the capacity to induce acetylation of histone and non-histone... 
Journal Article
Blood, ISSN 0006-4971, 11/2011, Volume 118, Issue 21, pp. 3581 - 3581
Abstract Abstract 3581 ALL cells are frequently characterized by deregulation of several intracellular signaling pathways involved in the control of... 
Journal Article
Blood, ISSN 0006-4971, 11/2010, Volume 116, Issue 21, pp. 3228 - 3228
Abstract Abstract 3228 Although they frequently achieve complete remission (CR), adult patients with acute lymphoblastic leukemia (ALL) subsequently experience... 
Journal Article
Blood, ISSN 0006-4971, 04/2009, Volume 113, Issue 15, pp. 3503 - 3511
There is much evidence to support a role for natural killer (NK) cells in controlling the progression of multiple myeloma (MM), a malignancy characterized by... 
NATURAL-KILLER-CELLS | DAMAGE RESPONSE | HLA CLASS-I | IMMUNE-SYSTEM | CANCER-TREATMENT | RECEPTOR | TUMOR-CELLS | NECTIN-2 CD112 | HEMATOLOGY | PVR CD155 | T-LYMPHOCYTES | Antibiotics, Antineoplastic - pharmacology | Tumor Suppressor Proteins - antagonists & inhibitors | Humans | GPI-Linked Proteins | Cellular Senescence - drug effects | Antineoplastic Agents, Alkylating - pharmacology | Multiple Myeloma - immunology | Pyrones - pharmacology | Cell Cycle Proteins - antagonists & inhibitors | DNA-Binding Proteins - metabolism | Intercellular Signaling Peptides and Proteins - metabolism | Cellular Senescence - immunology | Multiple Myeloma - drug therapy | Protein-Serine-Threonine Kinases - antagonists & inhibitors | Caffeine - pharmacology | Antineoplastic Agents - pharmacology | Melphalan - pharmacology | Protein-Serine-Threonine Kinases - metabolism | Tumor Suppressor Proteins - metabolism | DNA-Binding Proteins - antagonists & inhibitors | Cell Cycle Proteins - metabolism | Antigens, Differentiation, T-Lymphocyte - metabolism | Morpholines - pharmacology | Phosphodiesterase Inhibitors - pharmacology | Ataxia Telangiectasia Mutated Proteins | Cell Degranulation - immunology | Up-Regulation - drug effects | Killer Cells, Natural - cytology | Multiple Myeloma - pathology | Up-Regulation - immunology | Cell Line, Tumor | Killer Cells, Natural - drug effects | Doxorubicin - pharmacology | Cell Degranulation - drug effects | Index Medicus | Abridged Index Medicus
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2015, Volume 5, Issue 1, p. 18137
Journal Article
Journal Article